Clinical Trial Update: A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 safety study of lintuzumab in patients with acute myeloid leukemia and myelodysplastic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia
• Myeloproliferative Neoplasms

Drugs mentioned

• Lintuzumab (lintuzumab)

Snippet

Sponsor: Seagen Inc. | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | Status: COMPLETED